Clinical trial

HER2-low Unresectable and/or Metastatic Breast Cancer in Russia

NCT05913440

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2023-05-30

PhaseN/A

Study timeline

Study start (actual)2023-05-30Date precision: day

Registry last updated2026-03-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Interventions

Sponsors & collaborators

AstraZenecalead sponsor

Mapped research locations

MoscowRussia1 Saint PetersburgRussia1 NovosibirskRussia1 YaroslavlRussia1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05913440 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.